Hilton Capital Management’s Gilead Sciences GILD Stock Holding History

Hilton Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-700	Closed	-$44K	–	193
2019 Q3	$44K	Hold	700	–	–	0.01%	204
2019 Q2	$47K	Hold	700	–	–	0.01%	224
2019 Q1	$46K	Hold	700	–	–	0.01%	232
2018 Q4	$44K	Hold	700	–	–	0.01%	186
2018 Q3	$54K	Hold	700	–	–	0.01%	186
2018 Q2	$50K	Buy	+700	New	+$49.4K	0.01%	211
2016 Q4	–	Sell	-3,200	Closed	-$253K	–	123
2016 Q3	$253K	Hold	3,200	–	–	0.06%	108
2016 Q2	$267K	Hold	3,200	–	–	0.08%	72
2016 Q1	$294K	Sell	3,200 -34	-1%	-$3.07K	0.1%	70
2015 Q4	$327K	Sell	3,234 -500	-13%	-$52K	0.11%	66
2015 Q3	$367K	Buy	+3,734	New	+$415K	0.13%	61

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Hilton Capital Management's GILD Position: Q4 2019 in Review

Hilton Capital Management sold out of Gilead Sciences (GILD) in Q4 2019, closing a stake of 700 shares — an estimated $44K sold.

Hilton Capital Management first reported a position in GILD in Q3 2015 and held it in 11 quarters. The position peaked at $367K in Q3 2015. 1,555 funds tracked by Wall St. Rank hold GILD as of Q4 2019.

Hilton Capital Management reported no remaining Gilead Sciences position as of Q4 2019 after selling out during the quarter.
Hilton Capital Management sold 700 Gilead Sciences shares in Q4 2019, an estimated $44K.
Hilton Capital Management first reported a position in Gilead Sciences in Q3 2015 and held it in 11 quarters.
Hilton Capital Management's Gilead Sciences position peaked at $367K in Q3 2015.
1,555 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2019.

Based on Hilton Capital Management's 13F filing for Q4 2019, filed 13 Feb 2020.